Levels of serum interleukin (IL)-6, IL-1β, tumour necrosis factor-α and leptin and their correlation in depression

References

• Antonijevic IA. Depressive disorders: is it time to endorse different pathophysiologies?. Psychoneuroendocrinology 2006; 31: 1–15
   PubMed Web of Science ®Google Scholar
• Simmons DA, Broderick PA. Cytokines, stressors, and clinical depression: augmented adaptation responses underlie depression pathogenesis. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 793–807
   PubMed Web of Science ®Google Scholar
• Marques-Deak, AH, Lotufo Neto, F, Dominguez, WV, et al. Cytokine profiles in women with different subtypes of major depressive disorder. J Psychiatr Res 2005; 41:152–159.
   PubMed Web of Science ®Google Scholar
• Myint AM, Leonard BE, Steinbusch HW, Kim YK. Th1, Th2, and Th3 cytokine alterations in major depression. J Affect Disord 2005; 88: 167–173
   PubMed Web of Science ®Google Scholar
• Smith RS. The macrophage theory of depression. Med Hypotheses 1991; 35: 298–306
   PubMed Web of Science ®Google Scholar
• Capuron L, Miller AH. Cytokines and psychopathology: lessons from interferon-alpha. Biol Psychiatry 2004; 56): 819–824
   PubMed Web of Science ®Google Scholar
• Ushiroyama T, Ikeda A, Ueki M. Elevated plasma interleukin-6 (IL-6) and soluble IL-6 receptor concentrations in menopausal women with and without depression. Int J Gynecol Obstetr 2002; 79: 51–52
   PubMed Web of Science ®Google Scholar
• Kagaya A, Kugaya A, Takebayashi M, et al. Plasma concentrations of interleukin-1β, IL-6, sIL-2R and tumor necrosis factor alpha of depressed patients in Japan. Neuropsychobiology 2001; 43: 59–62
   PubMed Web of Science ®Google Scholar
• Rothermundt M, Arolt V, Peters M, et al. Inflammatory markers in major depression and melancholia. J Affect Disord 2001; 63: 93–102
   PubMed Web of Science ®Google Scholar
• Brambilla F, Monteleone P, Maj M. Interleukin-1beta and tumor necrosis factor-alpha in children with major depressive disorder or dysthymia. J Affect Disord 2004; 78: 273–277
   PubMed Web of Science ®Google Scholar
• Maes M, Bosmans E, Meltzer HY, Scharpe S, Suy E. Interleukin-1β: a putative mediator of HPA axis hyperactivity in major depression?. Am J Psychiatry 1993; 150: 1189–1193
   PubMed Web of Science ®Google Scholar
• Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 1995; 19: 11–38
   PubMed Web of Science ®Google Scholar
• Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H. Cytokine production and serum proteins in depression. Scand J Immunol 1995; 41: 534–538
   PubMed Web of Science ®Google Scholar
• Weizman R, Laor N, Podliszewski E, Notti I, Djaldetti M, Bessler H. Cytokine production in major depressed patients before and after clomipramine treatment. Biol Psychiatry 1994; 35: 42–47
   PubMed Web of Science ®Google Scholar
• Dubas-slemp H, Kaminska T, Marmurowska-Michalowska H, Kandefer-Szerszer M. Changes in serum concentrations and in cytokine production by blood cell cultures of a patient with major depression: case report. Ann Univ Marie Curie Sklodowska 2002; 57: 496–504
   PubMedGoogle Scholar
• Sluzewska, A, Rybakowski, J, Bosmans, E, et al. Indicators of immune activation in major depression. Psychiatry Res 1996; 64:161–167.
   PubMed Web of Science ®Google Scholar
• Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 2000; 22: 370–379
   PubMed Web of Science ®Google Scholar
• Jequier E. Leptin signaling, adiposity, and energy balance. Ann NY Acad Sci 2002; 967: 379–388
   PubMed Web of Science ®Google Scholar
• Deuschle M, Blum WF, Englaro P, et al. Plasma leptin in depressed patients and healthy controls. Horm Metab Res 1996; 28: 714–717
   PubMed Web of Science ®Google Scholar
• Antonijevic IA, Murck H, Frieboes RM, Horn R, Brabant G, Steiger A. Elevated nocturnal profiles of serum leptin in patients with depression. J Psychiatr Res 1998; 32: 403–410
   PubMed Web of Science ®Google Scholar
• Kraus T, Haack M, Schuld A, Hinze SD, Pollmacher T. Low leptin levels but normal body mass indices in patients with depression or schizophrenia. Neuroendocrinology 2001; 73: 243–247
   PubMed Web of Science ®Google Scholar
• Rubin RT, Rhodes ME, Czambel RK. Sexual diergism of baseline plasma leptin and leptin suppression by arginine vasopressin in major depressives and matched controls. Psychiatry Res 2002; 113: 255–268
   PubMed Web of Science ®Google Scholar
• Zhang, MY. The Chinese edition of Hamilton Depression Rating Scale and Hamilton Anxiety Rating Scale. In:. MY Zhang, ed., The handbook of rating scale in psychiatry branch of study. Changsha in Hunan: Science and Technology Press, 1993:81–127.
   Google Scholar
• Maes M. Cytokines in major depression. Biol Psychiatry 1994; 36: 498–499
   PubMed Web of Science ®Google Scholar
• Musselman L, Miller AH, Porter R, et al. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry 2001; 158: 1252–1257
   PubMed Web of Science ®Google Scholar
• Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H. Major depressive disorder is associated with elevated monocyte counts. Acta Psychiatr Scand 1996; 94: 198–204
   PubMed Web of Science ®Google Scholar
• Leonard BE. Changes in the immune system in depression and dementia: causal or co-incidental effects. Int J Dev Neurosci 2001; 19: 305–312
   PubMed Web of Science ®Google Scholar
• Wang J, Grunler J, Lewitt MS. Gender-specific pattern of insulin-like growth factor-binding protein-3 protease activity in mouse thyroid. Endocrinology 2004; 145: 1137–1143
   PubMed Web of Science ®Google Scholar
• Wichmann MW, Muller C, Meyer G, et al. Different immune responses to abdominal surgery in men and women. Langenbecks Arch Surg 2003; 387: 397–401
   PubMed Web of Science ®Google Scholar
• Haack M, Hinze-Selch D, Fenzel T, et al. Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. J Psychiatr Res 1999; 33: 407–418
   PubMed Web of Science ®Google Scholar
• Kraus T, Haack M, Schuld A, Hinze SD, Koethe D, Pollmacher T. Body weight, tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine. Pharmacopsychiatry 2002; 35: 220–225
   PubMed Web of Science ®Google Scholar
• Esel E, Ozsoy S, Tutus A, et al. Effects of antidepressant treatment and of gender on serum leptin levels in patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 565–570
   PubMed Web of Science ®Google Scholar
• Chan JL, Heist K, DePaoli AM, Veldhuis JD, Mantzoros CS. The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J Clin Invest 2003; 111: 1409–1421
   PubMed Web of Science ®Google Scholar
• Prud'homme GJ, Piccirillo CA. The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases. J Autoimmun 2000; 14: 23–42
   PubMed Web of Science ®Google Scholar
• Meyers JA, McTiernan A, Ulrich CM. Leptin and immune function: integrating the evidence. Nutr Res 2005; 25: 791–803
   Web of Science ®Google Scholar
• Mohamed-Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997; 82: 4196–4200
   PubMed Web of Science ®Google Scholar
• Bastard JP, Jardel C, Delattre J, Hainque B, Bruckert E, Oberlin F. Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects. Circulation 1999; 99: 2221–2222
   PubMed Web of Science ®Google Scholar
• Bastard JP, Jardel C, Bruckert E, et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000; 85: 3338–3342
   PubMed Web of Science ®Google Scholar
• Baumann H, Morella KK, White DW, et al. The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc Natl Acad Sci USA 1996; 93: 8374–8378
   PubMed Web of Science ®Google Scholar
• Finck BN, Johnson RW. Tumor necrosis factor-alpha regulates secretion of the adipocyte-derived cytokine, leptin. Microsc Res Tech 2000; 50: 209–215
   PubMed Web of Science ®Google Scholar
• Takahashi N, Waelput W, Guisez Y. Leptin is an endogenous protective protein against the toxicity exerted by tumor necrosis factor. J Exp Med 1999; 189: 207–212
   PubMed Web of Science ®Google Scholar
• Kirchgessner TG, Uysal KT, Wiesbrock SM, et al. Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest 1997; 100: 2777–2782
   PubMed Web of Science ®Google Scholar
• Licinio J, Negrao B, Mantzoros C, et al. Sex differences in circulating human leptin pulse amplitude: clinical implications. J Clin Endocrinol Metab 1998; 83: 4140–4147
   PubMed Web of Science ®Google Scholar
• Hennessey J. Leptin as fat orchestrator. Rev Undergrad Res 2003; 2: 12–18
   Google Scholar